A novel small molecule METTL3 inhibitor exerts promising antitumor effects on oral squamous cell carcinoma

被引：0
|
作者：
Arumugam, P. [1 ]
Jayaseelan, V. P. [2 ]
机构：
[1] Saveetha Inst Med & Tech Sci, Mol Biol, Chennai, Tamil Nadu, India
[2] Saveetha Inst Med & Tech Sci, Clin Genet, Chennai, Tamil Nadu, India
来源：
ANNALS OF ONCOLOGY | 2022年 / 33卷
关键词：
D O I：
10.1016/j.annonc.2022.01.016
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
14P
引用
收藏
页码：S8 / S8
页数：1
相关论文
共 50 条
  • [21] Antitumor Effect of Novel HSP90 Inhibitor NVP-AUY922 against Oral Squamous Cell Carcinoma
    Okui, Tatsuo
    Shimo, Tsuyoshi
    Hassan, Nur Mohammad Monsur
    Fukazawa, Takuya
    Kurio, Naito
    Takaoka, Munenori
    Naomoto, Yoshio
    Sasaki, Akira
    ANTICANCER RESEARCH, 2011, 31 (04) : 1197 - 1204
  • [22] Cepharanthine exerts antitumor activity on oral squamous cell carcinoma cell lines by induction of p27kip1
    Harada, K
    Supriatno
    Yamamoto, S
    Kawaguchi, S
    Yoshida, H
    Sato, M
    ANTICANCER RESEARCH, 2003, 23 (2B) : 1441 - 1448
  • [23] A Novel Small-Molecule Inhibitor of SREBP-1 Based on Natural Product Monomers Upregulates the Sensitivity of Lung Squamous Cell Carcinoma Cells to Antitumor Drugs
    Ma, De-Bin
    Liu, Xing-Yu
    Jia, Hui
    Zhang, Yingshi
    Jiang, Qiyu
    Sun, Huiwei
    Li, Xiaojuan
    Sun, Fang
    Chai, Yantao
    Feng, Fan
    Liu, Lei
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [24] Anlotinib as a promising inhibitor on tumor growth of oral squamous cell carcinoma through cell apoptosis and mitotic catastrophe
    Zhaoming Deng
    Wei Liao
    Wei Wei
    Guihua Zhong
    Chao He
    Hongbo Zhang
    Qiaodan Liu
    Xiwei Xu
    Jun Liang
    Zhigang Liu
    Cancer Cell International, 21
  • [25] Antitumor effects of BI-D1870 on human oral squamous cell carcinoma
    Chang-Fang Chiu
    Li-Yuan Bai
    Naval Kapuriya
    Shih-Yuan Peng
    Chia-Yung Wu
    Aaron M. Sargeant
    Michael Yuanchien Chen
    Jing-Ru Weng
    Cancer Chemotherapy and Pharmacology, 2014, 73 : 237 - 247
  • [26] Anlotinib as a promising inhibitor on tumor growth of oral squamous cell carcinoma through cell apoptosis and mitotic catastrophe
    Deng, Zhaoming
    Liao, Wei
    Wei, Wei
    Zhong, Guihua
    He, Chao
    Zhang, Hongbo
    Liu, Qiaodan
    Xu, Xiwei
    Liang, Jun
    Liu, Zhigang
    CANCER CELL INTERNATIONAL, 2021, 21 (01)
  • [27] Antitumor effects of BI-D1870 on human oral squamous cell carcinoma
    Chiu, Chang-Fang
    Bai, Li-Yuan
    Kapuriya, Naval
    Peng, Shih-Yuan
    Wu, Chia-Yung
    Sargeant, Aaron M.
    Chen, Michael Yuanchien
    Weng, Jing-Ru
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2014, 73 (02) : 237 - 247
  • [28] METTL3/m6A/IFIT2 regulates proliferation, invasion and immunity in esophageal squamous cell carcinoma
    Ge, Fangfang
    Li, Zhenyu
    Hu, Jiaru
    Pu, Youguang
    Zhao, Fangfang
    Kong, Lingsuo
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [29] METTL3 Facilitates Tumor Progression by COL12A1/MAPK Signaling Pathway in Esophageal Squamous Cell Carcinoma
    Li, Jiali
    Li, Zhenhua
    Xu, Yanzhao
    Huang, Chao
    Shan, Baoen
    JOURNAL OF CANCER, 2022, 13 (06): : 1972 - 1984
  • [30] Antitumor effects of bevacizumab in combination with fluoropyrimidine drugs on human oral squamous cell carcinoma
    Itashiki, Yasutaka
    Harada, Koji
    Takenawa, Takanori
    Ferdous, Tarannum
    Ueyama, Yoshiya
    Mishima, Katsuaki
    ONCOLOGY LETTERS, 2021, 22 (04)
12345